Warberg Asset Management’s Silexion Therapeutics SLXN Stock Holding History
Bought
Maintained
Sold
Other funds holding SLXN
RMI
BP
PK
Warberg Asset Management's SLXN Position: Q3 2026 in Review
Warberg Asset Management opened a new position in Silexion Therapeutics (SLXN) in Q3 2026: 9,394 shares worth $61.9K. The stake represents 0.01% of the portfolio and ranks #158 among its holdings.
10 funds tracked by Wall St. Rank hold SLXN as of Q3 2026.
- Warberg Asset Management held 9,394 shares of Silexion Therapeutics worth $61.9K as of Q3 2026.
- Silexion Therapeutics was a new Warberg Asset Management position in Q3 2026.
- Silexion Therapeutics made up 0.01% of Warberg Asset Management's portfolio in Q3 2026, its #158 holding.
- 10 funds tracked by Wall St. Rank held Silexion Therapeutics as of Q3 2026.
Based on Warberg Asset Management's 13F filing for Q3 2026, filed 2 Nov 2026.